Biofrontera
Germany - LeverkusenBiotechnology
Focus: Biofrontera is a dermatology-focused biotech company headquartered in Leverkusen, Germany, specializing in photodynamic therapy and topical treatments for skin lesions. The company operates a focused portfolio centered on aminolevulinate-based therapeutics and proprietary LED illumination systems.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Biofrontera
AI assessmentNot HiringNo open roles listed right now. Follow Biofrontera to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Biofrontera's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
LOE Approaching
AKTIPAK is approaching loss of exclusivity, signaling potential revenue erosion and need for pipeline replacement.
Help build intelligence for Biofrontera
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.